Systems Sales Lift Luminex's Q2 Revenues 2 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues grew 2 percent year over year, driven by a jump in instrument sales.

The Austin, Texas-based molecular diagnostics firm reported total revenues of $55.6 million for the three months ended June 30, compared to $54.3 million for the second quarter of 2012. It was slightly below analysts' consensus estimate for revenues of $55.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."